Skip to content

DaVinci Registry(Distinctly Assess Vision in Coronary Intervention)

Distinctly Access Vision In Coronary Interventions

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00243438
Enrollment
1300
Registered
2005-10-24
Start date
2003-07-31
Completion date
2005-03-31
Last updated
2009-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Disease

Brief summary

Prospective Internet-Registry, Postmarketing-Surveillance, Registration and Follow-up of patients after Multi-Link VISION™ - Stent Implantation

Detailed description

A Non-Randomized prospective evaluation of the Multi-Link Rx Vision TM Coronary Stent System in the treatment of patients with De novo native coronary artery lesions

Interventions

DEVICEMultilink Vision™ Stent (CE-labeled)

Patients who have diabetes and/or complex lesions and who have had a Multilink Vision™ Stent placed.

Sponsors

Abbott Medical Devices
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Women and Men Age \>18 years, Intention to treat all stenosis with Multi-Link VisionTM Stents, documented patient consent

Exclusion criteria

* No Multi-Link Vision™ Stent implanted, life expectation \>9 M, cardiogenic shock, STEMI, NSTEMI or unstable angina pectoris with pathologic markers within the last 48 hours, intolerance of Clopidogrel/ Tiklopidin

Design outcomes

Primary

MeasureTime frame
TVF9 months

Secondary

MeasureTime frame
Mode of death
Time to first MI
TVR
CABG

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026